title: Effect of Antipsychotic Dosing Regimen on Neurocognition in Schizophrenia.
authors.affiliation: Schizophrenia Division, Centre for Addiction and Mental Health, Department of Psychiatry, University of Toronto, Toronto, Canada and Department of Neuropsychiatry, Keio University School of Medicine, Tokyo, Japan hirotak@dk9.so-net.ne.jp Schizophrenia Division, Centre for Addiction and Mental Health and Institute of Medical Science, University of Toronto, Toronto, Canada Schizophrenia Division, Centre for Addiction and Mental Health, Department of Psychiatry, University of Toronto, Institute of Medical Science, University of Toronto and Campbell Family Mental Health Research Institute, Centre for Addiction and Mental Health, Toronto, Canada.
authors.forename: Hiroyoshi
authors.initials: H
authors.lastname: Takeuchi
authors.forename: Gagan
authors.initials: G
authors.lastname: Fervaha
authors.forename: Gary
authors.initials: G
authors.lastname: Remington
mesh_terms: D000328:Adult; D014150:Antipsychotic Agents / Q000008:administration & dosage / Q000494:pharmacology*; D003072:Cognition Disorders / Q000188:drug therapy* / Q000209:etiology; D004311:Double-Blind Method; D006801:Humans; D017063:Outcome Assessment, Health Care; D012559:Schizophrenia / Q000150:complications / Q000188:drug therapy*
chemical_list: D014150:Antipsychotic Agents